Therapeutic equivalence [Design Issues]

posted by raghu – India, 2011-02-09 11:07 (5605 d 10:35 ago) – Posting: # 6600
Views: 9,083

Dear Mr Kishore,

You can conduct BE study in healthy volunteers if the anticancer drug not shows any cytotoxic or any major health risk for participating healthy subjects.

Therapeutic equivalence study should be conducted in patients.

Regards
Raghu.

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
124 visitors (0 registered, 124 guests [including 15 identified bots]).
Forum time: 22:42 CEST (Europe/Vienna)

The idea is to try and give all the information to help others
to judge the value of your contribution;
not just the information that leads to judgment
in one particular direction or another.    Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5